Terms: = Sarcomas AND NRAS, N-ras, 4893, ENSG00000213281, P01111, NRAS1
283 results:
1.
de Traux de Wardin H; Dermawan JK; Vanoli F; Jiang SC; Singer S; Chi P; Tap W; Wexler LH; Antonescu CR
JCO Precis Oncol; 2024 Apr; 8():e2300597. PubMed ID: 38603649
[TBL] [Abstract] [Full Text] [Related]
2. A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced nras-mutant melanoma.
Wei X; Zou Z; Zhang W; Fang M; Zhang X; Luo Z; Chen J; Huang G; Zhang P; Cheng Y; Liu J; Liu J; Zhang J; Wu D; Chen Y; Ma X; Pan H; Jiang R; Liu X; Ren X; Tian H; Jia Z; Guo J; Si L
Eur J Cancer; 2024 May; 202():114008. PubMed ID: 38479118
[TBL] [Abstract] [Full Text] [Related]
3. Using tumor habitat-derived radiomic analysis during pretreatment
Zhao H; Su Y; Wang Y; Lyu Z; Xu P; Gu W; Tian L; Fu P
Cancer Imaging; 2024 Feb; 24(1):26. PubMed ID: 38342905
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
Pallocca M; Molineris I; Berrino E; Marcozzi B; Betti M; Levati L; D'Atri S; Menin C; Madonna G; Ghiorzo P; Bulgarelli J; Ferraresi V; Venesio T; Rodolfo M; Rivoltini L; Lanfrancone L; Ascierto PA; Mazzarella L; Pelicci PG; De Maria R; Ciliberto G; Medico E; Russo G
J Transl Med; 2024 Jan; 22(1):29. PubMed ID: 38184610
[TBL] [Abstract] [Full Text] [Related]
5. Colorectal Carcinoma With Sarcomatoid Components: Report of 15 Cases and Literature Review of an Exceedingly Rare Carcinoma Subtype.
Golconda U; McHugh KE; Allende DS; Collins K; Henn P; Lacambra M; Bejarano PA; Groisman GM; Loughrey MB; Monappa V; Zhang X; Hornick JL; Gonzalez RS
Am J Surg Pathol; 2024 Apr; 48(4):465-474. PubMed ID: 38155543
[TBL] [Abstract] [Full Text] [Related]
6. The diagnosis and treatment for primary cardiac angiosarcoma with n-ras gene mutation and MSI-L: A case report and review of the literature.
Sun J; Wei T; Sun B; Su J; Liu H; Wang D; Li X
Medicine (Baltimore); 2023 Dec; 102(51):e36682. PubMed ID: 38134104
[TBL] [Abstract] [Full Text] [Related]
7. Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entities.
Creus-Bachiller E; Fernández-Rodríguez J; Magallón-Lorenz M; Ortega-Bertran S; Navas-Rutete S; Romagosa C; Silva TM; Pané M; Estival A; Perez Sidelnikova D; Morell M; Mazuelas H; Carrió M; Lausová T; Reuss D; Gel B; Villanueva A; Serra E; Lázaro C
Mol Oncol; 2024 Apr; 18(4):895-917. PubMed ID: 37798904
[TBL] [Abstract] [Full Text] [Related]
8. Identification of genomic alterations with clinical impact in canine splenic hemangiosarcoma.
Estabrooks T; Gurinovich A; Pietruska J; Lewis B; Harvey G; Post G; Lambert L; Miller A; Rodrigues L; White ME; Lopes C; London CA; Megquier K
Vet Comp Oncol; 2023 Dec; 21(4):623-633. PubMed ID: 37734854
[TBL] [Abstract] [Full Text] [Related]
9. Mediastinal Epithelioid Angiosarcoma, New Insights into an Uncommon Diagnosis: A Case Report and Literature Review.
Navarro Sanchez JM; Oommen T; Lum C; Halford Z; Vierkoetter K
Hawaii J Health Soc Welf; 2023 Sep; 82(9):208-212. PubMed ID: 37694219
[TBL] [Abstract] [Full Text] [Related]
10. Oncologic relevance of genetic alterations in sporadic synchronous and solitary colorectal cancer: a retrospective multicenter study.
Son IT; Kim M; Oh BY; Kim MJ; Yoon SN; Park JH; Kim BC; Kim JW
BMC Gastroenterol; 2023 Sep; 23(1):297. PubMed ID: 37667167
[TBL] [Abstract] [Full Text] [Related]
11. Small molecular inhibitors for KRAS-mutant cancers.
Wu X; Song W; Cheng C; Liu Z; Li X; Cui Y; Gao Y; Li D
Front Immunol; 2023; 14():1223433. PubMed ID: 37662925
[TBL] [Abstract] [Full Text] [Related]
12. The histologic outcomes of indeterminate thyroid nodules with rat sarcoma mutations: A case series.
Jones M; Abendano DG; Turner M; Sullivan C; Reyes MCD
Diagn Cytopathol; 2023 Dec; 51(12):E332-E337. PubMed ID: 37583345
[TBL] [Abstract] [Full Text] [Related]
13. Recent advances in the development of inhibitors targeting KRAS-G12C and its related pathways.
Zhao D; Liu Y; Yi F; Zhao X; Lu K
Eur J Med Chem; 2023 Nov; 259():115698. PubMed ID: 37542991
[TBL] [Abstract] [Full Text] [Related]
14. Clinicopathological and molecular analyses of uterine carcinosarcomas using next-generation sequencing: A single-center experience.
Erdogan EG; Yalta TD; Can N; Süt N; Taştekin E; Usta U; Puyan FÖ; Usturalı Keskin FE; Kurt BB
Indian J Pathol Microbiol; 2023; 66(3):449-455. PubMed ID: 37530323
[TBL] [Abstract] [Full Text] [Related]
15. Shared hotspot mutations in oncogenes position dogs as an unparalleled comparative model for precision therapeutics.
Rodrigues L; Watson J; Feng Y; Lewis B; Harvey G; Post G; Megquier K; White ME; Lambert L; Miller A; Lopes C; Zhao S
Sci Rep; 2023 Jul; 13(1):10935. PubMed ID: 37414794
[TBL] [Abstract] [Full Text] [Related]
16. Gene Expression Profiling of Fibroepithelial Lesions of the Breast.
Li X; Vail E; Maluf H; Chaum M; Leong M; Lownik J; Che M; Giuliano A; Cao D; Dadmanesh F
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240386
[TBL] [Abstract] [Full Text] [Related]
17. [Clinicopathological features and prognosis of anorectal melanoma: A report of 68 cases].
Lai YM; Li ZW; Li H; Wu Y; Shi YF; Zhou LX; Lou YT; Cui CL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):262-269. PubMed ID: 37042136
[TBL] [Abstract] [Full Text] [Related]
18. Identification of novel peptide inhibitors for oncogenic KRAS G12D as therapeutic options using mutagenesis-based remodeling and MD simulations.
Samad A; Khurshid B; Mahmood A; Rehman AU; Khalid A; Abdalla AN; Algarni AS; Wadood A
J Biomol Struct Dyn; 2023; 41(22):13425-13437. PubMed ID: 37010994
[TBL] [Abstract] [Full Text] [Related]
19. Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue sarcomas: Mutational Signature Analysis and Immunotherapy Response.
Kasago IS; Chatila WK; Lezcano CM; Febres-Aldana CA; Schultz N; Vanderbilt C; Dogan S; Bartlett EK; D'Angelo SP; Tap WD; Singer S; Ladanyi M; Shoushtari AN; Busam KJ; Hameed M
Mod Pathol; 2023 Aug; 36(8):100165. PubMed ID: 36990277
[TBL] [Abstract] [Full Text] [Related]
20. Imaging Mass Spectrometry for the Classification of Melanoma Based on
Casadonte R; Kriegsmann M; Kriegsmann K; Streit H; Meliß RR; Müller CSL; Kriegsmann J
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982192
[TBL] [Abstract] [Full Text] [Related]
[Next]